Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1999 1
2001 1
2004 4
2005 2
2006 9
2007 8
2008 11
2009 2
2010 4
2011 2
2012 1
2013 4
2014 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 15238567

51 results

Results by year

Filters applied: . Clear all
Page 1
Trial of preventing hypertension: design and 2-year progress report.
Julius S, Nesbitt S, Egan B, Kaciroti N, Schork MA, Grozinski M, Michelson E; TROPHY study group. Julius S, et al. Hypertension. 2004 Aug;44(2):146-51. doi: 10.1161/01.HYP.0000130174.70055.ca. Epub 2004 Jul 6. Hypertension. 2004. PMID: 15238567 Clinical Trial.
Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N. Rakugi H, et al. Clin Ther. 2012 Apr;34(4):838-48. doi: 10.1016/j.clinthera.2012.02.015. Epub 2012 Mar 21. Clin Ther. 2012. PMID: 22440192 Clinical Trial.
A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
Palma Gámiz JL, Pêgo M, Contreras EM, Anglada MP, Martínez JO, Esquerra EA, Sagastagoitia Gorostiza JD; Iberian Multicenter Imidapril Study on Hypertension. Palma Gámiz JL, et al. Clin Ther. 2006 Dec;28(12):2040-51. doi: 10.1016/j.clinthera.2006.12.006. Clin Ther. 2006. PMID: 17296460 Clinical Trial.
A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
Radke PW, Figulla HR, Drexler H, Klues HG, Mügge A, Silber S, Daniel W, Schmeisser A, Reifart N, Motz W, Büttner HJ, Fischer D, Ortlepp JR, Schaefers K, Hoffmann R, Hanrath P; AACHEN Trial Investigators. Radke PW, et al. Am Heart J. 2006 Oct;152(4):761.e1-6. doi: 10.1016/j.ahj.2006.07.003. Am Heart J. 2006. PMID: 16996855 Clinical Trial.
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R. Philipp T, et al. Clin Ther. 2007 Apr;29(4):563-80. doi: 10.1016/j.clinthera.2007.03.018. Clin Ther. 2007. PMID: 17617280 Clinical Trial.
51 results